Why I'm backing ketamine for treatment-resistant depression

US psychiatrist on FDA expert panel says he voted with the majority to approve ketamine for the condition

Treatment-resistant depression affects one in three of the estimated 16.2 million adults in the US who have suffered at least one major depressive episode